Interleukin-1β may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation

Endocrinology

Volumn 151, Issue 9, 2010, Pages 4247-4256

  Nov, Ori ^a   Kohl, Ayelet ^a   Lewis, Eli C ^a   Bashan, Nava ^a   Dvir, Irit ^b   Ben Shlomo, Shani ^c   Fishman, Sigal ^c   Wueest, Stephan ^d,e   Konrad, Daniel ^d,e   Rudich, Assaf ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b SAPIR ACADEMIC COLLEGE   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT; GLYCOGEN SYNTHASE KINASE 3 ALPHA; INSULIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RESISTANCE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; CELL STRAIN 3T3; CELL STRAIN HEPG2; CULTURE MEDIUM; DRUG EFFECT; GENETICS; LIVER CELL CARCINOMA; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; GLYCOGEN SYNTHASE KINASE 3; HEP G2 CELLS; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77956029926     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0340     Document Type: Article

References (47)

1. Cancello R, Clément K 2006 Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 113:1141-1147 (Pubitemid 44401207)
2. Wisse BE 2004 The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15:2792-2800
3. Yudkin JS 2007 Inflammation, obesity, and the metabolic syndrome. Horm Metab Res 39:707-709
4. Shoelson SE, Herrero L, Naaz A 2007 Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169-2180
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
6. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830
7. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, Coussieu C, Basdevant A, Bar Hen A, Bedossa P, Guerre-Millo M, Clément K 2006 Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55:1554-1561
8. Harman-Boehm I, Blüher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Klöting N, Stumvoll M, Bashan N, Rudich A 2007 Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92:2240-2247
9. Strissel KJ, Stancheva Z, Miyoshi H, Perfield 2nd JW, DeFuria J, Jick Z, Greenberg AS, Obin MS 2007 Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56:2910-2918 (Pubitemid 350223625)
10. Saadeh S 2007 Nonalcoholic fatty liver disease and obesity. Nutr Clin Pract 22:1-10
11. Tilg H, Moschen AR 2008 Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 19:371-379
12. DeFronzo RA, Ferrannini E, Simonson DC 1989 Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395
13. Kim SP, Ellmerer M, Van Citters GW, Bergman RN 2003 Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 52:2453-2460
14. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI 1998 Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338:867-872
15. Juurinen L, Kotronen A, Granér M, Yki-Järvinen H 2008 Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses. J Clin Endocrinol Metab 93: 118-124
16. Rosenstock M, Greenberg AS, Rudich A 2001 Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-α in 3T3-L1 adipocytes. Diabetologia 44:55-62 (Pubitemid 32141885)
17. Souza SC, Yamamoto MT, Franciosa MD, Lien P, Greenberg AS 1998 BRL 49653 blocks the lipolytic actions of tumor necrosis factor-α: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes 47:691-695
18. McTernan PG, Harte AL, Anderson LA, Green A, Smith SA, Holder JC, Barnett AH, Eggo MC, Kumar S 2002 Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes 51:1493-1498 (Pubitemid 34826616)
19. Bruun JM, Lihn AS, Pedersen SB, Richelsen B 2005 Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneoushumanadipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90:2282-2289
20. Wang Z, Lv J, Zhang R, Zhu Y, Zhu D, Sun Y, Zhu J, Han X 2006 Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes. Biochem Biophys Res Commun 345:976-983
21. Zhou L, Sell H, Eckardt K, Yang Z, Eckel J 2007 Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes. FEBS Lett 581:4303-4308
22. Tirosh A, Potashnik R, Bashan N, Rudich A 1999 Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 274:10595-10602
23. Bloch-Damti A, Potashnik R, Gual P, Le Marchand-Brustel Y, Tanti JF, Rudich A, Bashan N 2006 Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress. Diabetologia 49:2463-2473 (Pubitemid 44359109)
24. Berry MN, Friend DS 1969 High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43:506-520
25. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, Riley T, Howard TA, Michalopoulos GK 1996 Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF α in a chemically defined (HGM) medium. J Cell Biol 132:1133-1149 (Pubitemid 26105500)
26. Wueest S, Rapold RA, Schumann DM, Rytka JM, Schildknecht A, Nov O, Chervonsky AV, Rudich A, Schoenle EJ, Donath MY, Konrad D2010 Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J Clin Invest 120: 191-202
27. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A 1993 Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268: 26055-26058
28. Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB 2008 TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferonresponse genes. Nat Immunol 9:378-387
29. Wang B, Jenkins JR, Trayhurn P 2005 Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-α. Am J Physiol Endocrinol Metab 288:E731-E740
30. Zhang HH, Kumar S, Barnett AH, Eggo MC 2001 Dexamethasone inhibits tumor necrosis factor-α-induced apoptosis and interleu-kin-1β release in human subcutaneous adipocytes and preadipocytes. J Clin Endocrinol Metab 86:2817-2825
31. Jager J, Grémeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF 2007 Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241-251 (Pubitemid 46021456)
32. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Lulka D, Walczak M 2005 Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. Neuroendocrinol Lett 26:242-246
33. Aygun AD, Gungor S, Ustundag B, Gurgoze MK, Sen Y 2005 Proinflammatory cytokines and leptin are increased in serum of prepubertal obese children. Mediators Inflamm 2005:180-183
34. Juge-Aubry CE, Somm E, Giusti V, Pernin A, Chicheportiche R, Verdumo C, Rohner-Jeanrenaud F, Burger D, Dayer JM, Meier CA 2003 Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 52: 1104-1110
35. Juge-Aubry CE, Somm E, Chicheportiche R, Burger D, Pernin A, Cuénod-Pittet B, Quinodoz P, Giusti V, Dayer JM, Meier CA 2004 Regulatory effects of interleukin (IL)-1, interferon-β, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab 89:2652-2658
36. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY 2007 Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526 (Pubitemid 46588416)
37. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM 2007 Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 293:E656-E665
38. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulangé A, Capeau J, Caron M 2006 Long-term treatment with interleukin- 1β induces insulin resistance in murine and human adipocytes. Diabetologia 49:2162-2173
39. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF 2003 Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817
40. Turtzo LC, Marx R, Lane MD 2001 Cross-talk between sympathetic neurons and adipocytes in coculture. Proc Natl Acad Sci USA 98:12385-12390 (Pubitemid 33019955)
41. Suganami T, Nishida J, Ogawa Y 2005 A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 25:2062-2068
42. Dietze D, Koenen M, Röhrig K, Horikoshi H, Hauner H, Eckel J 2002 Impairment of insulin signaling in human skeletal muscle cells by coculture with human adipocytes. Diabetes 51:2369-2376
43. Venieratos PD, Drossopoulou GI, Kapodistria KD, Tsilibary EC, Kitsiou PV 2010 High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1β and suppressor of cytokine signalling-1 in mouse pancreatic β cells. Cell Signal 22:791-800
44. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW 2004 Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273-2282
45. Arner P 2002 Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 18(Suppl 2):S5-S9 (Pubitemid 34467308)
46. Verna EC, Berk PD 2008 Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis 28:407-426
47. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, Davis RJ 2008 A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322:1539-1543